Health
Pfizer vaccine can neutralise coronavirus variants first reported in UK, South Africa: Study – Hindustan Times
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants.
The Covid-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.
According to the scientists, including those from the University of Texas in the US, these…
-
Noosa News22 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News22 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay
-
Noosa News23 hours agoBidding for a good cause
-
Noosa News22 hours agoMurray Watt slams Queensland LNP renewable energy policy